Liaoning He Eye Hospital Group (301103.SZ) issues a profit warning, expecting a net loss of 20.5 million to 30.75 million yuan in 2024, turning from profit to loss.
He Medical Ophthalmology (301103.SZ) released the 2024 annual performance forecast, with the company expecting...
Liaoning He Eye Hospital Group (301103.SZ) released the performance forecast for the year 2024, with the company expecting a net loss attributable to shareholders of the listed company of 20.5 million yuan to 30.75 million yuan, a switch from profit to loss; a net loss of 22 million yuan to 32.5 million yuan after deducting non-recurring gains and losses, also a switch from profit to loss.
During the reporting period, intensified industry competition and the impact of healthcare payment reform caused a decrease in the company's revenue and gross profit. The company has invested heavily in innovative business, digitalization, and R&D projects, resulting in increased cost and expense compared to the same period last year.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






